← All trials
NCT03343392
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 5, 2016
- Primary completion
- Oct 1, 2017
- Completion date
- Oct 13, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 114
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Universidade Estadual de Ponta GrossaLead sponsor
- Universidade Estadual de Ponta GrossaReponsible party - principal investigator
- Universidade Federal do ParanaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.